Started: 5/2017
Study Name: A Phase 2, Open-Label Study to Evaluate the Safety, Efficacy and Systemic Exposure of XXX Topical Film Forming Solution [0.7% (w/v) XXX in Subjects (2 years and older) with Molluscum Contagiosum
Indication: Molluscum
Principal Investigator: Brad Brabec